Integra Lifesciences Holdings Corp
Could not find a ticker for this position, may be a filing error
A maker of surgical and medical devices used by neurosurgeons, reconstructive surgeons, and general surgeons. Its best-known product is the Integra Dermal Regeneration Template, a bioengineered "artificial skin" scaffold that helps severe burn victims grow new skin. The company was founded in 1989 by Dr. Richard Caruso, who licensed the collagen-scaffold technology developed at MIT and Harvard. Its name reflects the product's purpose: the matrix integrates with the patient's own body to regenerate tissue.
1.625% Convertible Senior Notes due December 15, 2016
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| PARADIGM CAPITAL MANAGEMENT INC/NY | 13G/APassive | — | — | Aug 13, 2026 |
| Vanguard Portfolio Management | 13GPassive | 5.02% | 3.91M | Jul 31, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 27, 2026 |
| Fuller & Thaler Asset Management, Inc. | 13G/APassive | 4.67% | 3.64M | Feb 17, 2026 |
| Invesco Ltd. | 13G/APassive | 4.5% | 3.49M | Nov 6, 2025 |
| Morgan Stanley | 13G/APassive | 4.3% | 3.38M | Aug 5, 2025 |
| BlackRock, Inc. | 13G/APassive | 13.2% | 10.28M | Jul 17, 2025 |
| Rubric Capital Management LP | 13G/APassive | 9.46% | 7.35M | Jul 9, 2025 |
| David Rosen | 13G/APassive | 9.46% | 7.35M | Jul 9, 2025 |